Clinical Trials

266 enrolled

Breast Neoplasms

NCT00469339 2026-03-11

Risk Communication Within Mexican-American Families

498 enrolled

BreastGastrointestinal

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus

NCT00040222 2026-03-09

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

377 enrolled

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT00475761 2026-03-09

Breast Mammogram and Tissue Study

466 enrolled

Breast Neoplasms

NCT00043472 2026-01-05

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

40 enrolled

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT03199885 2025-12-30

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

190 enrolled 12 charts

Breast Neoplasms

NCT01273168 2025-12-23

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

40 enrolled

BreastGynecologicSarcoma

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT00861705 2025-09-30

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

454 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00770809 2025-08-15

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

305 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01149083 2025-08-15

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

77 enrolled 17 charts

Breast Neoplasms

NCT01275677 2025-07-14

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

3,270 enrolled 16 charts

Breast Neoplasms

NCT00923104 2025-07-08

An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin

61 enrolled

BreastGenitourinary

Blister, Breast Neoplasms, Prostatic Neoplasms

NCT00601900 2025-05-23

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

394 enrolled 11 charts

Breast Neoplasms

NCT02595905 2025-05-16

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

344 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01349959 2025-04-27

Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

58 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00026754 2025-04-18

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

BreastDermatologicGenitourinarySarcomaThoracic

19,522 enrolled

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms, Sarcoma, Skin Diseases, HIV Infections

NCT02767986 2024-09-03

Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance

22 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT00341939 2024-06-13

Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data

BreastDermatologicGenitourinaryLymphoidThoracic

484 enrolled

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT01468883 2024-04-26

The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

256 enrolled

Breast Neoplasms

NCT00096434 2024-03-07

Sorafenib in Treating Patients With Metastatic Breast Cancer

23 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00020267 2024-03-04

Vaccine Therapy in Treating Patients With Metastatic Cancer

BreastDermatologicGastrointestinalSarcomaThoracic

Uveal Melanoma, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Eye Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Osteosarcoma, Skin Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Breast Neoplasms, Male, Muscle Neoplasms, Genetic Diseases, Inborn, Histiocytoma, Malignant Fibrous

NCT00342446 2024-01-11

A Follow-up Study of Women Evaluated and Treated for Infertility

BreastDermatologicGastrointestinalGynecologicHead & Neck

12,193 enrolled

Breast Neoplasms, Melanoma, Ovarian Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT01142401 2023-11-27

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

118 enrolled 11 charts

Breast Neoplasms

NCT01622868 2023-10-17

Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer

143 enrolled 24 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT02598557 2023-08-22

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

180 enrolled 46 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT00001503 2023-06-18

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

BreastDermatologicGenitourinaryGynecologicLymphoid

1,031 enrolled

Breast Neoplasms, Lymphoma, Melanoma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT00028340 2023-01-10

High-Risk Breast Duct Epithelium

156 enrolled

Breast Neoplasms

NCT00785291 2022-10-10

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

799 enrolled 18 charts

Breast Neoplasms

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

33 enrolled 18 charts

BreastDermatologicGenitourinaryGynecologic

Adenocarcinoma, Breast Neoplasms

NCT02111850 2022-03-29

T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive

Phase 1/2 Completed

21 enrolled 22 charts

Breast Neoplasms, Uterine Cervical Neoplasms, Kidney Neoplasms, Melanoma

NCT01849250 2021-12-28

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

65 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary

NCT02317367 2021-08-30

Self-Affirmation: Construct Validity

3,112 enrolled

Alcohol Drinking, Breast Neoplasms, Risk Reduction Behavior

NCT01967823 2021-03-24

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

BreastCNSDermatologicGastrointestinalThoracic

11 enrolled 12 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Melanoma, Meningioma, Neoplasm Metastasis

NCT00470301 2021-02-16

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Phase 1/2 Completed

60 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02179515 2021-01-26

Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)

BreastGenitourinaryGynecologicThoracic

38 enrolled 20 charts

Breast Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT01582074 2020-12-28

The Ultrasound Study of Tamoxifen

247 enrolled

Breast Neoplasms

NCT00006425 2020-11-27

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study

20 enrolled

Breast Neoplasms

NCT00340600 2020-11-16

Continuation of Follow-up of DES-Exposed Cohorts

BreastGenitourinaryGynecologic

10,805 enrolled

Autoimmune Diseases, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT00340210 2020-09-10

Extended Follow-up of Columbia, MO Serum Bank Participants

6,720 enrolled

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00005970 2020-08-14

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

3,436 enrolled

Breast Neoplasms

NCT01461070 2020-05-27

Intestine Bacteria and Breast Cancer Risk

175 enrolled

Breast Neoplasms

NCT02911155 2020-05-05

Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists

229 enrolled

BreastCNSHead & Neck

Brain Neoplasms, Breast Neoplasms, Thyroid Neoplasms

NCT00341692 2020-04-29

Studying Normal Breast Tissue and Cancer Risk

13 enrolled

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

NCT00341458 2020-04-20

Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics

6,086 enrolled

Breast Neoplasms, Gonadal Disorders, Ovarian Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT00342407 2020-04-10

The Incidence of Breast and Other Cancers Among Female Flight Attendants

BreastDermatologicHead & Neck

6,093 enrolled

Breast Neoplasms, Melanoma, Thyroid Neoplasms

NCT00860886 2020-04-10

Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer

412 enrolled

Breast Neoplasms

NCT01736306 2020-03-31

Biomarkers for Breast Cancer Risk in African American Women

260 enrolled

Breast Neoplasms

NCT00340262 2020-03-30

Bone Mineral Density and Subsequent Cancer Risk

15,595 enrolled

Breast Neoplasms, Osteoporosis, Endometrial Neoplasms

NCT00684983 2020-03-24

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

64 enrolled 13 charts